Cost-effectiveness of lumbar artificial intervertebral disc replacement: driven by the choice of comparator
Background Lower back pain is a common and costly condition in Australia. This paper aims to conduct an economic evaluation of lumbar artificial intervertebral disc replacement (AIDR) compared with lumbar fusion for the treatment of patients suffering from significant axial back pain and/or radicula...
Saved in:
Published in | ANZ journal of surgery Vol. 83; no. 9; pp. 669 - 675 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Australia
Blackwell Publishing Ltd
01.09.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Lower back pain is a common and costly condition in Australia. This paper aims to conduct an economic evaluation of lumbar artificial intervertebral disc replacement (AIDR) compared with lumbar fusion for the treatment of patients suffering from significant axial back pain and/or radicular (nerve root) pain, secondary to disc degeneration or prolapse, who have failed conservative treatment.
Methods
A cost‐effectiveness approach was used to compare costs and benefits of AIDR to five fusion approaches. Resource use was based on Medicare Benefits Schedule claims data and expert opinion. Effectiveness and re‐operation rates were based on published randomized controlled trials. The key clinical outcomes considered were narcotic medication discontinuation, achievement of overall clinical success, achievement of Oswestry Disability Index success and quality‐adjusted life‐years gained.
Results
AIDR was estimated to be cost‐saving compared with fusion overall ($1600/patient); however, anterior lumbar interbody fusion and posterolateral fusion were less costly by $2155 and $807, respectively. The incremental cost‐effectiveness depends on the outcome considered and the comparator.
Conclusions
AIDR is potentially a cost‐saving treatment for lumbar disc degeneration, although longer‐term follow‐up data are required to substantiate this claim. The incremental cost‐effectiveness depends on the outcome considered and the comparator, and further research is required before any firm conclusions can be drawn. |
---|---|
Bibliography: | istex:087BC151E836C84F8F8D8B8E0064BE2E13B45A30 ArticleID:ANS12009 ark:/67375/WNG-0BQLQ18D-J ANZ Journal of Surgery, v.83, no.9, Sept 2013: (669)-675 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1445-1433 1445-2197 |
DOI: | 10.1111/ans.12009 |